SAN FRANCISCO — Monsanto Co. has lost out on an early bid to knock out more than 400 federal cases claiming that the active ingredient in its Roundup herbicide causes a type of cancer.

In what he called “a very close question,” U.S. District Judge Vince Chhabria of the Northern District of California, who is overseeing the cases, declined to grant Monsanto’s motion for summary judgment that plaintiffs couldn’t prove that the glyphosate in Roundup causes non-Hodgkin lymphoma (NHL), a type of cancer affecting white blood cells. Although Chhabria wrote that evidence plaintiffs put forward “seems too equivocal to support any firm conclusion that glyphosate causes NHL,” he found that they could put on admissible evidence that could convince a reasonable jury to conclude otherwise.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]